Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hypertransaminasemia in cancer patients receiving immunotherapy and immune-based combinations: the MOUSEION-05 study
Alessandro Rizzo, Veronica Mollica, Valentina Tateo, et al.
Cancer Immunology Immunotherapy (2023) Vol. 72, Iss. 6, pp. 1381-1394
Closed Access | Times Cited: 112

Showing 1-25 of 112 citing articles:

The impact of ECOG performance status on efficacy of immunotherapy and immune-based combinations in cancer patients: the MOUSEION-06 study
Veronica Mollica, Alessandro Rizzo, Andrea Marchetti, et al.
Clinical and Experimental Medicine (2023) Vol. 23, Iss. 8, pp. 5039-5049
Closed Access | Times Cited: 126
Calculus bovis inhibits M2 tumor-associated macrophage polarization via Wnt/β-catenin pathway modulation to suppress liver cancer
Zhen Huang, Fanying Meng, Lin-Zhu Lu, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 29, pp. 3511-3533
Open Access | Times Cited: 23
0,1,2,3D nanostructures, types of bulk nanostructured materials, and drug nanocrystals: An overview
Ali Assim Adul-Rasool, Duaa Mohammed Athair, Haider Kamil Zaidan, et al.
Cancer Treatment and Research Communications (2024) Vol. 40, pp. 100834-100834
Open Access | Times Cited: 15
Preclinical study of inetetamab combined with atezolizumab to synergistically inhibit HER2 and PD-L1 in the treatment of ovarian cancer
Feiquan Ying, Xuyang Zhou, Mengqing Chen, et al.
Deleted Journal (2025) Vol. 33, Iss. 1, pp. 200938-200938
Open Access | Times Cited: 1
Efficacy and safety of different drugs in patients with HER2-positive gastric cancer: network meta-analysis
Jie Zhang, Chunluan Yuan, Xiao Ma
Systematic Reviews (2025) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Napabucasin deactivates STAT3 and promotes mitoxantrone-mediated cGAS-STING activation for hepatocellular carcinoma chemo-immunotherapy
Lingzhi Wang, Shengnan Bi, Zhuo Li, et al.
Biomaterials (2024) Vol. 313, pp. 122766-122766
Closed Access | Times Cited: 8
Evaluation of peripheral blood inflammation indexes as prognostic markers for colorectal cancer metastasis
Xin Shen, Mengying Xiang, Jiadai Tang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Myeloid cell differentiation-related gene signature for predicting clinical outcome, immune microenvironment, and treatment response in lung adenocarcinoma
Di Wu, Yibing Liu, Jianjun Liu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Explainable machine learning models for early gastric cancer diagnosis
Hongyang Du, Qingfen Yang, Aimin Ge, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Bioinformatics analysis to disclose shared molecular mechanisms between type-2 diabetes and clear-cell renal-cell carcinoma, and therapeutic indications
Reaz Ahmmed, Md. Bayazid Hossen, Alvira Ajadee, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Prognostication of colorectal cancer liver metastasis by CE-based radiomics and machine learning
Xijun Luo, Hui Deng, Fei Xie, et al.
Translational Oncology (2024) Vol. 47, pp. 101997-101997
Open Access | Times Cited: 4
Personalized neoantigen cancer vaccines: current progression, challenges and a bright future
Dawei Wu, Shuopeng Jia, Shujun Xing, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Role of glucose metabolic reprogramming in colorectal cancer progression and drug resistance
Rong Qin, Xirui Fan, Yun‐Wen Huang, et al.
Translational Oncology (2024) Vol. 50, pp. 102156-102156
Open Access | Times Cited: 4
Hepatocellular Carcinoma Immunotherapy: Predictors of Response, Issues, and Challenges
Alessandro Rizzo, Oronzo Brunetti, Giovanni Brandi
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11091-11091
Open Access | Times Cited: 4
Enhancing Melanoma Diagnostic: Harnessing the Synergy of AI and CNNs for Groundbreaking Advances in Early Melanoma Detection and Treatment Strategies
Muhammad Sajid, Ali Haider Khan, Tauqeer Safdar Malik, et al.
International Journal of Imaging Systems and Technology (2024) Vol. 35, Iss. 1
Open Access | Times Cited: 4
Predictive factors of chemotherapy‑induced nausea and vomiting in elderly patients with gynecological cancer undergoing paclitaxel and carboplatin therapy: A retrospective study
Fei Yao, Lijuan He, Xingyu Sun
Oncology Letters (2025) Vol. 29, Iss. 4
Open Access
First‐Line Treatment of Icaritin and Thalidomide in a Patient With Hepatocellular Carcinoma With PR: A Case Report
Zhi‐Cheng Jin, Fei Zhou, Zhuo Wang, et al.
Cancer Reports (2025) Vol. 8, Iss. 3
Open Access
Liquid biopsy for guiding breast cancer immunotherapy
Emanuela Fina, Elsa Vitale, Simona De Summa, et al.
Immunotherapy (2025), pp. 1-15
Closed Access
Case Report: Second-line favourable effect of pembrolizumab plus chemotherapy in a patient with metastatic hepatoid adenocarcinoma of the stomach
Yao Tang, Xiaofen Li, Yu‐Xiao Yang
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Comparison of different treatment strategies for T3N1-3 stage gastric cancer based on the SEER database
Yimei Tan, Shuanghua Liu, Shaohong Tao, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
A nomogram for predicting the risk of cancer-related cognitive impairment in breast cancer patients based on a scientific symptom model
Zhongtao Zhou, Jiajia Ren, Qiankun Liu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Metformin induces tumor immunogenic cell death in ovarian cancer by activating AMPK pathway
Yixiong Chen, Lufang Wang, Na Chen, et al.
Translational Oncology (2024) Vol. 47, pp. 102052-102052
Open Access | Times Cited: 3
Employing antagonistic C-X-C motif chemokine receptor 4 antagonistic peptide functionalized NaGdF4 nanodots for magnetic resonance imaging-guided biotherapy of breast cancer
Xiaodong Li, Yunkai Bao, Zhuheng Li, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Optimizing the resveratrol fragments for novel in silico hepatocellular carcinoma de novo drug design
Muhammad Naveed, Khushbakht Javed, Tariq Aziz, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Lenvatinib‑based treatment regimens in conversion therapy of unresectable hepatocellular carcinoma: A systematic review and meta‑analysis
Saixin Li, Zeyu Zhang, Zheng Wang, et al.
Oncology Letters (2024) Vol. 27, Iss. 6
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top